Adrenal: Pheochromocytoma: Difference between revisions
Urology4all (talk | contribs) |
Urology4all (talk | contribs) |
||
| Line 254: | Line 254: | ||
* Postoperative cross-sectional imaging is reasonable to document tumor resection and appropriate healing of the resection bed. | * Postoperative cross-sectional imaging is reasonable to document tumor resection and appropriate healing of the resection bed. | ||
** Subsequent imaging should be guided by results of biochemical testing | ** Subsequent imaging should be guided by results of biochemical testing | ||
* '''Annual biochemical follow-up is mandatory for all patients with resected pheochromocytoma.''' | * '''<span style="color:#ff0000">Annual biochemical follow-up is mandatory for all patients with resected pheochromocytoma.''' | ||
* '''Lifelong screening for recurrence is recommended''' | * '''<span style="color:#ff0000">Lifelong screening for recurrence is recommended''' | ||
** 10-year recurrence rates are as high as 16%. | ** 10-year recurrence rates are as high as 16%. | ||
** No consensus on follow-up protocols exists. | ** No consensus on follow-up protocols exists. | ||